Restrictive cardiomyopathy is a type of heart disease in which the ventricles of the heart become stiff and lose their ability to relax normally between heartbeats. This stiffness makes it difficult for the heart to fill with blood, which can lead to a decrease in blood flow to the rest of the body. Unlike other types of cardiomyopathy, in restrictive cardiomyopathy the size of the ventricles is usually normal or near normal, and the heart’s pumping function (systolic function) can be maintained into the later stages of the disease. Restrictive cardiomyopathy can affect either the left or right ventricle, or both.
The impact of restrictive cardiomyopathy on health can be significant. Difficulty filling the heart properly can lead to symptoms of heart failure, such as fatigue, shortness of breath, and swelling in the legs and ankles. In the long term, restrictive cardiomyopathy can damage other organs in the body due to a lack of oxygen and nutrients.
Symptoms of restrictive cardiomyopathy
Symptoms of restrictive cardiomyopathy can vary from person to person, and some people may not experience any symptoms in the early stages of the disease. As restrictive cardiomyopathy progresses, the most common symptoms include:
Fatigue and weakness.
Difficulty breathing (dyspnea),
especially during exercise or while lying down.
Swelling (edema) in the legs,
ankles, or abdomen.
Persistent cough.
Dizziness or vertigo.
Palpitations
(a feeling of fast or irregular heartbeats).
It is important to keep in mind that these symptoms can be caused by many other medical conditions, so it is essential to consult a doctor to obtain an accurate diagnosis.
Classification of restrictive cardiomyopathy
Restrictive cardiomyopathy is not a single entity, but can manifest in various ways. Understanding how the disease is classified is crucial for determining its underlying cause and guiding treatment. The different types of restrictive cardiomyopathy are described below according to their origin and characteristics:
Idiopathic restrictive cardiomyopathy: in this type, the cause of restrictive cardiomyopathy is unknown.
Familial restrictive cardiomyopathy:caused by inherited genetic mutations.
Secondary restrictive cardiomyopathy: this type of restrictive cardiomyopathy is caused by another disease or condition, such as amyloidosis, sarcoidosis, or hemochromatosis.
Causes of restrictive cardiomyopathy
Restrictive cardiomyopathy can be due to hereditary or acquired predispositions and diseases, or a combination of these, which can be broadly classified as infiltrative, storage, fibrotic, and endomyocardial. Most causes of restrictive cardiomyopathy are acquired (not hereditary).
Factors that can cause restrictive cardiomyopathy include:
Amyloidosis: a disease in which abnormal proteins called amyloids are deposited in tissues and organs, including the heart.
Sarcoidosis: an inflammatory disease that can affect multiple organs, including the heart.
Hemochromatosis: a disease in which the body accumulates too much iron, which can damage the heart and other organs.
Certain genetic diseases: some rare genetic diseases can cause restrictive cardiomyopathy.
Cancer treatments: radiotherapy and some chemotherapy drugs can damage the heart and cause restrictive cardiomyopathy.
Other medical conditions: in rare cases, restrictive cardiomyopathy can be caused by other medical conditions, such as scleroderma or endomyocardial fibrosis.
Unknown causes: In some cases, the cause of restrictive cardiomyopathy cannot be determined.
While restrictive cardiomyopathy can affect people of all ages, there are some factors that may increase the risk of developing the disease. Identifying these risk factors can help take preventive measures and increase awareness of symptoms. The following are some of the most significant risk factors:
Old age: restrictive cardiomyopathy is more common in older adults.
Family history: having a relative with cardiomyopathy can increase the risk of developing the disease.
Other diseases: having amyloidosis, sarcoidosis, hemochromatosis, or other medical conditions increases the risk of developing restrictive cardiomyopathy.
Previous treatment with radiation: having received radiotherapy or chemotherapy increases the risk of developing restrictive cardiomyopathy.
Complications of restrictive cardiomyopathy
If not properly managed, restrictive cardiomyopathy can lead to several If not treated properly, restrictive cardiomyopathy can lead to a range of complications that affect the health and quality of life of patients. It is crucial to be aware of these potential complications in order to seek early medical attention and follow an appropriate treatment plan. The following are some of the most common complications:
Heart failure: the heart cannot pump enough blood to meet the body’s needs.
Arrhythmias: irregular heart rhythms that can be life-threatening.
Blood clots: blood clots can form in the heart, which can travel to other organs and cause a stroke or heart attack.
Sudden cardiac death: in rare cases, restrictive cardiomyopathy can lead to sudden cardiac death.
If you suspect you have restrictive cardiomyopathy, consult a specialist to obtain an accurate diagnosis and an appropriate treatment plan tailored to your needs.
Diagnosis of restrictive cardiomyopathy
The diagnosis of restrictive cardiomyopathy requires a thorough evaluation by a specialist physician. The diagnostic process involves a combination of tests and procedures designed to assess the structure and function of the heart, as well as to identify possible underlying causes.
The most common diagnostic methods and procedures used in the detection of restrictive cardiomyopathy are described below:
Physical examination: the doctor will ask about symptoms and medical history, and will perform a physical exam to assess for signs of heart failure, such as swelling in the limbs or difficulty breathing.
Electrocardiogram (ECG): this test measures the electrical activity of the heart and can help detect arrhythmias or other heart problems, such as bundle branch blocks or low voltages, which may suggest cardiac amyloidosis. However, an ECG alone is not sufficient to diagnose restrictive cardiomyopathy.
Echocardiogram: this test uses sound waves to create an image of the heart and is a fundamental tool for evaluating the size, shape, and function of the ventricles, as well as for detecting abnormalities in diastolic filling. The echocardiogram may show a restrictive filling pattern, biatrial dilation, and normal or increased ventricular wall thickness. Two-dimensional echocardiography and Doppler are essential to determine diastolic dysfunction and to distinguish people with restrictive cardiomyopathy from people with restrictive physiology due to constrictive pericarditis.
Cardiac magnetic resonance imaging (MRI): this test uses magnets and radio waves to create detailed images of the heart and can help identify the cause of restrictive cardiomyopathy. Cardiac MRI is especially useful for detecting cardiac amyloidosis, sarcoidosis, and other infiltrative diseases, as it can show characteristic patterns of late gadolinium enhancement. It also allows for the evaluation of ventricular function and the detection of myocardial fibrosis.
Endomyocardial biopsy: in this procedure, a small sample of heart tissue is removed for examination under a microscope. Endomyocardial biopsy is the gold standard for confirming the diagnosis of cardiac amyloidosis and may be necessary when other tests are inconclusive. However, due to the irregular nature of some diseases, such as cardiac sarcoidosis, a biopsy may not always be diagnostic.
Cardiac catheterization: a catheter is inserted into a blood vessel and guided to the heart to measure pressures in the different heart chambers. Cardiac catheterization can help confirm the diagnosis of restrictive cardiomyopathy by demonstrating a restrictive filling pattern, with elevated pressures in the atria and ventricles. This test can also help rule out other causes of heart failure, such as pericardial constriction.
The doctor may recommend additional tests, such as blood tests to detect amyloids or genetic testing, to determine the cause of restrictive cardiomyopathy and assess the severity of the disease.
At HM Hospitales, we have Cardiology units, with a comprehensive care service for people with heart problems, providing access to state-of-the-art technology to diagnose and treat cardiomyopathies.
Treatment for restrictive cardiomyopathy
Treatment for restrictive cardiomyopathy focuses on relieving symptoms, preventing complications, and improving quality of life. Treatment options are tailored to the individual needs of each patient and may include a combination of medications, lifestyle changes, and medical procedures. The following are some of the most common treatment options for restrictive cardiomyopathy:
Lifestyle changes: these changes are essential to control symptoms and improve quality of life. This may include following a low-sodium diet to reduce fluid retention, limiting fluid intake to avoid volume overload, and exercising regularly, as tolerated, to improve cardiovascular function.
Medications: several medications can be used to control the symptoms of restrictive cardiomyopathy, including diuretics, antiarrhythmics, beta-blockers, and anticoagulants. Diuretics can be used to reduce fluid retention and relieve shortness of breath and swelling. It is important to carefully control the dose of diuretics to avoid dehydration and an excessive decrease in cardiac output. Antiarrhythmic medications are used to control irregular heart rhythms, such as atrial fibrillation. And anticoagulants can be used to prevent the formation of blood clots, especially in cases of atrial fibrillation or a history of thrombi. Beta-blockers can also be used to control heart rate and reduce blood pressure.
Implantable devices: in some cases, a pacemaker may be implanted to improve coordination between the atria and ventricles, or an implantable cardioverter-defibrillator (ICD) may be used to prevent sudden cardiac death in people at risk of ventricular arrhythmias. Furthermore, left ventricular assist device (LVAD) therapy may be particularly suitable for people with restrictive cardiomyopathy as a bridge to transplantation or as definitive therapy.
Surgery: in rare cases, surgery may be recommended to remove scar tissue from the heart (myectomy) or to replace a damaged heart valve if there is significant stenosis or valvular insufficiency. In severe cases of restrictive cardiomyopathy that do not respond to other treatments, a heart transplant may be considered. However, a heart transplant is not an option for everyone, and eligibility depends on several factors, including age, overall health, and the presence of other medical conditions.
The specific treatment plan for restrictive cardiomyopathy will depend on the cause of the disease, the severity of the symptoms, and other individual factors. A multidisciplinary team of specialists may be necessary, including cardiologists, electrophysiologists, cardiac surgeons, and cardiac rehabilitation specialists.
Remember that this article is for informational purposes only and does not replace professional medical advice. If you suspect you have restrictive cardiomyopathy, consult a specialist to obtain an accurate diagnosis and an appropriate treatment plan tailored to your needs.
Our Specialists
Consult and book an appointment with our leading cardiology professionals.
